60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne Diseases

PartnershipcastanosperminePositive

AI Analysis

Summary

60 Degrees Pharmaceuticals secured an exclusive option agreement with Florida State University to develop castanospermine for tick-borne diseases, expanding its infectious disease pipeline.

Importance:6/10

Sentiment:

0.60

partnershiplicensinginfectious diseasedrug developmentoption agreement

Related Companies

$SXTP

Read the original article

Published by GlobeNewswire Pharma on July 8, 2026 12:01 PM

Read Original